(INNS)
ALEMTUZUMAB BETA(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS CD52 (CD52 ANTIGEN, CAMPATH-1 ANTIGEN, CDW52)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-451) [VH (HOMO SAPIENS IGHV4-30-4*01 (73.5%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT [8.10.12] (26-33.51-60.99-110)) (1-121) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1, CH1 K120, CH3 D12, L14 (CH1 K120 (218) (122-219), HINGE 1-15 (220-234), CH2 (235-344), CH3 D12 (360), L14 (362) (345-449), CHS (450-451)) (122-451)], (224- 214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'- 214') [V-KAPPA (HOMO SAPIENS IGKV1-33*01 (86.3%) -IGKJ1*01 (100%), CDR-IMGT [6.3.9] (27-32.50- 52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (153), V101 (191) (108'-214')]; DIMER (230- 230'':233-233'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA(WHO)
ALEMTUZUMABUM BETA(INN)